Ngx Bio Closes $3M Funding Round

The round was led by 180 Degree Capital Corp. (NASDAQ:TURN) with participation from Third Kind Venture Capital, Lateral Capital, the Band of Angels and the Berkeley Angel Network, as well as other investors.

The company intends to use the funds to continue to expand operations.

Founded in 2014 and led by Denis Kourakin, President and Chief Executive Officer, Ngx Bio aims to provide streamlined, on-line access to next-generation sequencing services for clients seeking sequencing of both human and non-human samples globally.
The platform matches the sequencing needs of customers with providers who have available sequencing capacity. Customers are able to purchase a wide range of sequencing services for their samples using an online ordering tools.